Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgical Wound Infection | 2 | 2023 | 126 | 1.360 |
Why?
|
| Obstetric Labor Complications | 3 | 2015 | 24 | 1.260 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 2015 | 61 | 1.230 |
Why?
|
| Diabetes, Gestational | 3 | 2024 | 142 | 1.110 |
Why?
|
| Pregnancy | 14 | 2024 | 2390 | 1.010 |
Why?
|
| Cesarean Section | 2 | 2023 | 102 | 0.840 |
Why?
|
| Antiemetics | 1 | 2023 | 97 | 0.730 |
Why?
|
| Preoperative Care | 1 | 2023 | 199 | 0.700 |
Why?
|
| Patient Care Team | 1 | 2024 | 336 | 0.680 |
Why?
|
| Labor, Obstetric | 1 | 2019 | 35 | 0.580 |
Why?
|
| Vancomycin | 1 | 2018 | 40 | 0.560 |
Why?
|
| Streptococcus agalactiae | 1 | 2018 | 81 | 0.550 |
Why?
|
| Vagina | 1 | 2018 | 87 | 0.550 |
Why?
|
| Streptococcal Infections | 1 | 2018 | 85 | 0.550 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2018 | 71 | 0.540 |
Why?
|
| Puerperal Disorders | 1 | 2017 | 15 | 0.510 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 225 | 0.500 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 1161 | 0.460 |
Why?
|
| Insulin | 1 | 2019 | 695 | 0.450 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 389 | 0.420 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 806 | 0.370 |
Why?
|
| Female | 14 | 2024 | 34193 | 0.370 |
Why?
|
| Postpartum Period | 2 | 2024 | 188 | 0.360 |
Why?
|
| Parturition | 2 | 2023 | 54 | 0.330 |
Why?
|
| Glucose Tolerance Test | 2 | 2024 | 97 | 0.330 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 732 | 0.300 |
Why?
|
| Humans | 14 | 2024 | 65463 | 0.260 |
Why?
|
| Capsaicin | 1 | 2023 | 19 | 0.200 |
Why?
|
| Pilot Projects | 2 | 2024 | 1021 | 0.190 |
Why?
|
| Obstetrics | 1 | 2024 | 91 | 0.190 |
Why?
|
| Anal Canal | 1 | 2023 | 38 | 0.190 |
Why?
|
| Nausea | 1 | 2023 | 111 | 0.180 |
Why?
|
| Vomiting | 1 | 2023 | 139 | 0.180 |
Why?
|
| Emergency Medicine | 1 | 2024 | 194 | 0.170 |
Why?
|
| Time Factors | 2 | 2019 | 3774 | 0.170 |
Why?
|
| Blood Glucose | 2 | 2024 | 502 | 0.160 |
Why?
|
| Rhode Island | 1 | 2019 | 110 | 0.150 |
Why?
|
| Colony Count, Microbial | 1 | 2018 | 58 | 0.140 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 160 | 0.140 |
Why?
|
| Gestational Age | 1 | 2019 | 194 | 0.140 |
Why?
|
| Physicians | 1 | 2024 | 482 | 0.140 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 202 | 0.130 |
Why?
|
| Infant, Newborn | 2 | 2019 | 1431 | 0.130 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 2776 | 0.120 |
Why?
|
| Adult | 4 | 2024 | 17461 | 0.120 |
Why?
|
| Cervical Length Measurement | 1 | 2015 | 6 | 0.110 |
Why?
|
| Progestins | 1 | 2015 | 29 | 0.110 |
Why?
|
| Cervix Uteri | 1 | 2015 | 58 | 0.110 |
Why?
|
| Progesterone | 1 | 2015 | 165 | 0.110 |
Why?
|
| Fetal Distress | 1 | 2014 | 2 | 0.100 |
Why?
|
| Heart Rate, Fetal | 1 | 2014 | 3 | 0.100 |
Why?
|
| Fetal Monitoring | 1 | 2014 | 7 | 0.100 |
Why?
|
| Acid-Base Imbalance | 1 | 2014 | 4 | 0.100 |
Why?
|
| Free Radicals | 1 | 2014 | 19 | 0.100 |
Why?
|
| Fetal Diseases | 1 | 2014 | 22 | 0.100 |
Why?
|
| Hyperoxia | 1 | 2014 | 16 | 0.100 |
Why?
|
| Premature Birth | 1 | 2015 | 116 | 0.100 |
Why?
|
| Resuscitation | 1 | 2014 | 67 | 0.100 |
Why?
|
| Risk Factors | 1 | 2022 | 5458 | 0.090 |
Why?
|
| Prospective Studies | 1 | 2018 | 3324 | 0.080 |
Why?
|
| Blood Pressure Determination | 1 | 2024 | 40 | 0.050 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2024 | 53 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2024 | 535 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 808 | 0.040 |
Why?
|
| Telemedicine | 1 | 2024 | 373 | 0.040 |
Why?
|
| Mass Screening | 1 | 2024 | 700 | 0.030 |
Why?
|
| Hospitalization | 1 | 2024 | 1399 | 0.030 |
Why?
|
| Administration, Intravaginal | 1 | 2015 | 12 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 36 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2015 | 64 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 318 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 194 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 6929 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 2111 | 0.020 |
Why?
|